Biofrontera Inc.
NASDAQ: BFRI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Hermann Lübbert
- Employees
- 88
- Headquarters
- Woburn, United States
- IPO year
- 2021
- Market cap
- $12.8M
- Website
- https://www.biofrontera-us.com
Loading BFRI…
Loading profile data…Frequently asked questions about BFRI
What does Biofrontera Inc. (BFRI) do?
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. Th...
Where does BFRI trade?
Biofrontera Inc. (BFRI) trades on the NASDAQ.
What sector is BFRI in?
Biofrontera Inc. (BFRI) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Biofrontera Inc.?
Hermann Lübbert is the chief executive officer of Biofrontera Inc. (BFRI).
Where is Biofrontera Inc. headquartered?
Biofrontera Inc. is headquartered in United States.
Does BFRI pay a dividend?
Biofrontera Inc. (BFRI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BFRI go public?
Biofrontera Inc. (BFRI) completed its initial public offering in 2021.